MicroRNA Signature Predicts Survival and Relapse in Lung Cancer

Cancer Cell

Volumn 13, Issue 1, 2008, Pages 48-57

  Yu, Sung Liang ^a,b   Chen, Hsuan Yu ^a,c,d   Chang, Gee Chen ^f,g   Chen, Chih Yi ^f,h   Chen, Huei Wen ⁱ   Singh, Sher ^j   Cheng, Chiou Ling ^a   Yu, Chong Jen ^b   Lee, Yung Chie ^b   Chen, Han Shiang ^k   Su, Te Jen ^a,g   Chiang, Ching Cheng ^a   Li, Han Ni ^a   Hong, Qi Sheng ^a   Su, Hsin Yuan ^a   Chen, Chun Chieh ^a   Chen, Wan Jiun ⁱ   Liu, Chun Chi ^g   Chan, Wing Kai ^b   Chen, Wei J ^a,c   Li, Ker Chau ^d,l   Chen, Jeremy J W ^a,g   Yang, Pan Chyr ^a,b,e   more..

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d INSTITUTE OF STATISTICAL SCIENCE   (Taiwan)

^e INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^f TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^g NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^h Institute of Medicine   (Taiwan)

ⁱ NATIONAL YANG MING UNIVERSITY   (Taiwan)

^j NATIONAL TAIWAN NORMAL UNIVERSITY   (Taiwan)

^k BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^l UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

CELLCYCLE

Indexed keywords

BIOLOGICAL MARKER; MICRORNA;

ADULT; AGED; ARTICLE; CANCER RELAPSE; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LUNG CANCER; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REAL TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; TREATMENT OUTCOME; TUMOR SUPPRESSOR GENE; VALIDATION PROCESS;

EID: 37349096992     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2007.12.008     Document Type: Article

References (46)

1. Bast Jr. R.C., and Hortobagyi G.N. Individualized care for patients with cancer-A work in progress. N. Engl. J. Med. 351 (2004) 2865-2867
2. Beer D.G., Kardia S.L., Huang C.C., Giordano T.J., Levin A.M., Misek D.E., Lin L., Chen G., Gharib T.G., Thomas D.G., et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat. Med. 8 (2002) 816-824
3. Bloomston M., Frankel W.L., Petrocca F., Volinia S., Alder H., Hagan J.P., Liu C.G., Bhatt D., Taccioli C., and Croce C.M. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 297 (2007) 1901-1908
4. Calin G.A., and Croce C.M. MicroRNA-cancer connection: The beginning of a new tale. Cancer Res. 66 (2006) 7390-7394
5. Calin G.A., and Croce C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 6 (2006) 857-866
6. Calin G.A., Ferracin M., Cimmino A., Di Leva G., Shimizu M., Wojcik S.E., Iorio M.V., Visone R., Sever N.I., Fabbri M., et al. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N. Engl. J. Med. 353 (2005) 1793-1801
7. Chen J.J., Peck K., Hong T.M., Yang S.C., Sher Y.P., Shih J.Y., Wu R., Cheng J.L., Roffler S.R., Wu C.W., and Yang P.C. Global analysis of gene expression in invasion by a lung cancer model. Cancer Res. 61 (2001) 5223-5230
8. Chen H.Y., Yu S.L., Chen C.H., Chang G.C., Chen C.Y., Yuan A., Cheng C.L., Wang C.H., Terng H.J., Kao S.F., et al. A five-gene signature and clinical outcome in non-small-cell lung cancer. N. Engl. J. Med. 356 (2007) 11-20
9. Cox D.R. Regression models and life-tables. J. Roy. Statist. Soc. Ser. B. Methodological 34 (1972) 187-220
10. Cummins J.M., and Velculescu V.E. Implications of micro-RNA profiling for cancer diagnosis. Oncogene 25 (2006) 6220-6227
11. Czech M.P. MicroRNAs as therapeutic targets. N. Engl. J. Med. 354 (2006) 1194-1195
12. Endoh H., Tomida S., Yatabe Y., Konishi H., Osada H., Tajima K., Kuwano H., Takahashi T., and Mitsudomi T. Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction. J. Clin. Oncol. 22 (2004) 811-819
13. Esquela-Kerscher A., and Slack F.J. Oncomirs-MicroRNAs with a role in cancer. Nat. Rev. Cancer 6 (2006) 259-269
14. Felli N., Fontana L., Pelosi E., Botta R., Bonci D., Facchiano F., Liuzzi F., Lulli V., Morsilli O., Santoro S., et al. MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc. Natl. Acad. Sci. USA 102 (2005) 18081-18086
15. Flanigan R.C., Salmon S.E., Blumenstein B.A., Bearman S.I., Roy V., McGrath P.C., Caton Jr. J.R., Munshi N., and Crawford E.D. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N. Engl. J. Med. 345 (2001) 1655-1659
16. Galardi S., Mercatelli N., Giorda E., Massalini S., Frajese G.V., Ciafre S.A., and Farace M.G. miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27kip1. J. Biol. Chem. 282 (2007) 23716-23724
17. Garzon R., Fabbri M., Cimmino A., Calin G.A., and Croce C.M. MicroRNA expression and function in cancer. Trends Mol. Med. 12 (2006) 580-587
18. Green S., Benedetti J., and Crowley J. Statistical concepts. In: Green S., Benedetti J., and Crowley J. (Eds). Clinical Trials in Oncology (Interdisciplinary Statistics) (2003), Chapman & Hall/CRC, Boca Raton 11-40
19. Gregory R.I., and Shiekhattar R. MicroRNA biogenesis and cancer. Cancer Res. 65 (2005) 3509-3512
20. Grosshans H., Johnson T., Reinert K.L., Gerstein M., and Slack F.J. The temporal patterning microRNA let-7 regulates several transcription factors at the larval to adult transition in C. elegans. Dev. Cell 8 (2005) 321-330
21. Hammond S.M. MicroRNAs as oncogenes. Curr. Opin. Genet. Dev. 16 (2006) 4-9
22. The International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N. Engl. J. Med. 350 (2004) 351-360
23. Iorio M.V., Ferracin M., Liu C.G., Veronese A., Spizzo R., Sabbioni S., Magri E., Pedriali M., Fabbri M., Campiglio M., et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 65 (2005) 7065-7070
24. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., and Thun M.J. Cancer statistics, 2006. CA Cancer J. Clin. 56 (2006) 106-130
25. Jiang J., Lee E.J., Gusev Y., and Schmittgen T.D. Real-time expression profiling of microRNA precursors in human cancer cell lines. Nucleic Acids Res. 33 (2005) 5394-5403
26. Johnson S.M., Grosshans H., Shingara J., Byrom M., Jarvis R., Cheng A., Labourier E., Reinert K.L., Brown D., and Slack F.J. RAS is regulated by the let-7 microRNA family. Cell 120 (2005) 635-647
27. Koch G.G., and Gillings D.B. Tests, one-sided versus two-sided. In: Kotz S., Johnson N.L., and Read C.B. (Eds). Encyclopedia of Statistical Sciences (1988), Wiley, New York 218-221
28. Lee Y.S., and Dutta A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev. 21 (2007) 1025-1030
29. Lossos I.S., Czerwinski D.K., Alizadeh A.A., Wechser M.A., Tibshirani R., Botstein D., and Levy R. Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N. Engl. J. Med. 350 (2004) 1828-1837
30. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B.L., Mak R.H., Ferrando A.A., et al. MicroRNA expression profiles classify human cancers. Nature 435 (2005) 834-838
31. Ludwig J.A., and Weinstein J.N. Biomarkers in cancer staging, prognosis and treatment selection. Nat. Rev. Cancer 5 (2005) 845-856
32. Mayr C., Hemann M.T., and Bartel D.P. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 315 (2007) 1576-1579
33. Miller Y.E. Pathogenesis of lung cancer: 100 year report. Am. J. Respir. Cell Mol. Biol. 33 (2005) 216-223
34. Olaussen K.A., Dunant A., Fouret P., Brambilla E., Andre F., Haddad V., Taranchon E., Filipits M., Pirker R., Popper H.H., et al. DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N. Engl. J. Med. 355 (2006) 983-991
35. Poliseno L., Tuccoli A., Mariani L., Evangelista M., Citti L., Woods K., Mercatanti A., Hammond S., and Rainaldi G. MicroRNAs modulate the angiogenic properties of HUVEC. Blood 108 (2006) 3068-3071
36. Potti A., Mukherjee S., Petersen R., Dressman H.K., Bild A., Koontz J., Kratzke R., Watson M.A., Kelley M., Ginsburg G.S., et al. A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N. Engl. J. Med. 355 (2006) 570-580
37. Ramaswamy S. Translating cancer genomics into clinical oncology. N. Engl. J. Med. 350 (2004) 1814-1816
38. Roldo C., Missiaglia E., Hagan J.P., Falconi M., Capelli P., Bersani S., Calin G.A., Volinia S., Liu C.G., Scarpa A., and Croce C.M. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J. Clin. Oncol. 24 (2006) 4677-4684
39. Seymour M.T., Maughan T.S., Ledermann J.A., Topham C., James R., Gwyther S.J., Smith D.B., Shepherd S., Maraveyas A., Ferry D.R., et al. Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): A randomised controlled trial. Lancet 370 (2007) 143-152
40. Shridhar R., Zhang J., Song J., Booth B.A., Kevil C.G., Sotiropoulou G., Sloane B.F., and Keppler D. Cystatin M suppresses the malignant phenotype of human MDA-MB-435S cells. Oncogene 23 (2004) 2206-2215
41. Simon R., Radmacher M.D., Dobbin K., and McShane L.M. Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. J. Natl. Cancer Inst. 95 (2003) 14-18
42. Takamizawa J., Konishi H., Yanagisawa K., Tomida S., Osada H., Endoh H., Harano T., Yatabe Y., Nagino M., Nimura Y., et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 64 (2004) 3753-3756
43. Tang F., Hajkova P., Barton S.C., Lao K., and Surani M.A. MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res. 34 (2006) e9
44. Volinia S., Calin G.A., Liu C.G., Ambs S., Cimmino A., Petrocca F., Visone R., Iorio M., Roldo C., Ferracin M., et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA 103 (2006) 2257-2261
45. Voorhoeve P.M., le Sage C., Schrier M., Gillis A.J., Stoop H., Nagel R., Liu Y.P., van Duijse J., Drost J., Griekspoor A., et al. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 124 (2006) 1169-1181
46. Yanaihara N., Caplen N., Bowman E., Seike M., Kumamoto K., Yi M., Stephens R.M., Okamoto A., Yokota J., Tanaka T., et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9 (2006) 189-198